The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients
Abstract The ZIPANGU study assessed the efficacy and safety of ranibizumab as a one loading dose + pro re nata (one + PRN) regimen with/without focal/grid laser among treatment-naïve patients suffering from macular edema (ME) following branch retinal vein occlusion (BRVO). ZIPANGU was a phase IV, pr...
Main Authors: | Toshinori Murata, Mineo Kondo, Makoto Inoue, Shintaro Nakao, Rie Osaka, Chieko Shiragami, Kenji Sogawa, Akikazu Mochizuki, Rumiko Shiraga, Yohei Ohashi, Takeumi Kaneko, Chikatapu Chandrasekhar, Akitaka Tsujikawa, Motohiro Kamei |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-79051-1 |
Similar Items
-
Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients
by: Toshinori Murata, et al.
Published: (2021-07-01) -
Metamorphopsia Associated with Branch Retinal Vein Occlusion.
by: Koichiro Manabe, et al.
Published: (2016-01-01) -
Persistent metamorphopsia associated with branch retinal vein occlusion.
by: Rie Osaka, et al.
Published: (2018-01-01) -
Metamorphopsia associated with central retinal vein occlusion.
by: Koichiro Manabe, et al.
Published: (2017-01-01) -
Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
by: Tatsuya Yoshitake, et al.
Published: (2019-05-01)